Exact Mass: 465.2282
Exact Mass Matches: 465.2282
Found 500 metabolites which its exact mass value is equals to given mass value 465.2282
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA
Glycyl-histidyl-arginyl-proline
Luminespib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
(7S,13E,16S,17R,18S,19E)-22-oxa-(12)-cytochalasa-5,13,19-triene-1,21-dione-7,17-dihydroxy-16,18-dimethyl-10-phenyl|cytochalasin Z8
Ala Phe Gln Thr
Ala Phe Thr Gln
Ala Gly Arg Tyr
Ala Gly Tyr Arg
Ala Asn Val Tyr
Ala Asn Tyr Val
Ala Gln Phe Thr
Ala Gln Thr Phe
Ala Arg Gly Tyr
Ala Arg Tyr Gly
Ala Thr Phe Gln
Ala Thr Gln Phe
Ala Val Asn Tyr
Ala Val Tyr Asn
Ala Tyr Gly Arg
Ala Tyr Asn Val
Ala Tyr Arg Gly
Ala Tyr Val Asn
Cys Cys Ile Lys
Cys Cys Lys Ile
Cys Cys Lys Leu
Cys Cys Leu Lys
Cys Ile Cys Lys
Cys Ile Lys Cys
Cys Lys Cys Ile
Cys Lys Cys Leu
Cys Lys Ile Cys
Cys Lys Leu Cys
Cys Leu Cys Lys
Cys Leu Lys Cys
Asp Phe Gly Lys
Asp Phe Lys Gly
Asp Gly Phe Lys
Asp Gly Lys Phe
Asp Lys Phe Gly
Asp Lys Gly Phe
Phe Ala Gln Thr
Phe Ala Thr Gln
Phe Asp Gly Lys
Phe Asp Lys Gly
Phe Gly Asp Lys
Phe Gly Lys Asp
Phe Gly Arg Ser
Phe Gly Ser Arg
Phe Lys Asp Gly
Phe Lys Gly Asp
Phe Asn Ser Val
Phe Asn Val Ser
Phe Gln Ala Thr
Phe Gln Thr Ala
Phe Arg Gly Ser
Phe Arg Ser Gly
Phe Ser Gly Arg
Phe Ser Asn Val
Phe Ser Arg Gly
Phe Ser Val Asn
Phe Thr Ala Gln
Phe Thr Gln Ala
Phe Val Asn Ser
Phe Val Ser Asn
Gly Ala Arg Tyr
Gly Ala Tyr Arg
Gly Asp Phe Lys
Gly Asp Lys Phe
Gly Phe Asp Lys
Gly Phe Lys Asp
Gly Phe Arg Ser
Gly Phe Ser Arg
Gly His Pro Arg
Gly His Arg Pro
Gly Ile Asn Tyr
Gly Ile Tyr Asn
Gly Lys Asp Phe
Gly Lys Phe Asp
Gly Lys Met Met
Gly Leu Asn Tyr
Gly Leu Tyr Asn
Gly Met Lys Met
Gly Met Met Lys
Gly Asn Ile Tyr
Gly Asn Leu Tyr
Gly Asn Tyr Ile
Gly Asn Tyr Leu
Gly Pro His Arg
Gly Pro Arg His
Gly Gln Val Tyr
Gly Gln Tyr Val
Gly Arg Ala Tyr
Gly Arg Phe Ser
Gly Arg His Pro
Gly Arg Pro His
Gly Arg Ser Phe
Gly Arg Tyr Ala
Gly Ser Phe Arg
Gly Ser Arg Phe
Gly Val Gln Tyr
Gly Val Tyr Gln
Gly Tyr Ala Arg
Gly Tyr Ile Asn
Gly Tyr Leu Asn
Gly Tyr Asn Ile
Gly Tyr Asn Leu
Gly Tyr Gln Val
Gly Tyr Arg Ala
Gly Tyr Val Gln
His Gly Pro Arg
His Gly Arg Pro
His Asn Pro Val
His Asn Val Pro
His Pro Gly Arg
His Pro Asn Val
His Pro Arg Gly
His Pro Val Asn
His Arg Gly Pro
His Arg Pro Gly
His Val Asn Pro
His Val Pro Asn
Ile Cys Cys Lys
Ile Cys Lys Cys
Ile Gly Asn Tyr
Ile Gly Tyr Asn
Ile Lys Cys Cys
Ile Asn Gly Tyr
Ile Asn Tyr Gly
Ile Tyr Gly Asn
Ile Tyr Asn Gly
Lys Cys Cys Ile
Lys Cys Cys Leu
Lys Cys Ile Cys
Lys Cys Leu Cys
Lys Asp Phe Gly
Lys Asp Gly Phe
Lys Phe Asp Gly
Lys Phe Gly Asp
Lys Gly Asp Phe
Lys Gly Phe Asp
Lys Gly Met Met
Lys Ile Cys Cys
Lys Leu Cys Cys
Lys Met Gly Met
Lys Met Met Gly
Lys Met Ser Thr
Lys Met Thr Ser
Lys Ser Met Thr
Lys Ser Thr Met
Lys Thr Met Ser
Lys Thr Ser Met
Leu Cys Cys Lys
Leu Cys Lys Cys
Leu Gly Asn Tyr
Leu Gly Tyr Asn
Leu Lys Cys Cys
Leu Asn Gly Tyr
Leu Asn Tyr Gly
Leu Tyr Gly Asn
Leu Tyr Asn Gly
Met Gly Lys Met
Met Gly Met Lys
Met Lys Gly Met
Met Lys Met Gly
Met Lys Ser Thr
Met Lys Thr Ser
Met Met Gly Lys
Met Met Lys Gly
Met Ser Lys Thr
Met Ser Thr Lys
Met Thr Lys Ser
Met Thr Ser Lys
Asn Ala Val Tyr
Asn Ala Tyr Val
Asn Phe Ser Val
Asn Phe Val Ser
Asn Gly Ile Tyr
Asn Gly Leu Tyr
Asn Gly Tyr Ile
Asn Gly Tyr Leu
Asn His Pro Val
Asn His Val Pro
Asn Ile Gly Tyr
Asn Ile Tyr Gly
Asn Leu Gly Tyr
Asn Leu Tyr Gly
Asn Pro His Val
Asn Pro Val His
Asn Ser Phe Val
Asn Ser Val Phe
Asn Val Ala Tyr
Asn Val Phe Ser
Asn Val His Pro
Asn Val Pro His
Asn Val Ser Phe
Asn Val Tyr Ala
Asn Tyr Ala Val
Asn Tyr Gly Ile
Asn Tyr Gly Leu
Asn Tyr Ile Gly
Asn Tyr Leu Gly
Asn Tyr Val Ala
Pro Gly His Arg
Pro Gly Arg His
Pro His Gly Arg
Pro His Asn Val
Pro His Arg Gly
Pro His Val Asn
Pro Asn His Val
Pro Asn Val His
Pro Arg Gly His
Pro Arg His Gly
Pro Val His Asn
Pro Val Asn His
Gln Ala Phe Thr
Gln Ala Thr Phe
Gln Phe Ala Thr
Gln Phe Thr Ala
Gln Gly Val Tyr
Gln Gly Tyr Val
Gln Thr Ala Phe
Gln Thr Phe Ala
Gln Val Gly Tyr
Gln Val Tyr Gly
Gln Tyr Gly Val
Gln Tyr Val Gly
Arg Ala Gly Tyr
Arg Ala Tyr Gly
Arg Phe Gly Ser
Arg Phe Ser Gly
Arg Gly Ala Tyr
Arg Gly Phe Ser
Arg Gly His Pro
Arg Gly Pro His
Arg Gly Ser Phe
Arg Gly Tyr Ala
Arg His Gly Pro
Arg His Pro Gly
Arg Pro Gly His
Arg Pro His Gly
Arg Ser Phe Gly
Arg Ser Gly Phe
Arg Tyr Ala Gly
Arg Tyr Gly Ala
Ser Phe Gly Arg
Ser Phe Asn Val
Ser Phe Arg Gly
Ser Phe Val Asn
Ser Gly Phe Arg
Ser Gly Arg Phe
Ser Lys Met Thr
Ser Lys Thr Met
Ser Met Lys Thr
Ser Met Thr Lys
Ser Asn Phe Val
Ser Asn Val Phe
Ser Arg Phe Gly
Ser Arg Gly Phe
Ser Thr Lys Met
Ser Thr Met Lys
Ser Val Phe Asn
Ser Val Asn Phe
Thr Ala Phe Gln
Thr Ala Gln Phe
Thr Phe Ala Gln
Thr Phe Gln Ala
Thr Lys Met Ser
Thr Lys Ser Met
Thr Met Lys Ser
Thr Met Ser Lys
Thr Gln Ala Phe
Thr Gln Phe Ala
Thr Ser Lys Met
Thr Ser Met Lys
Val Ala Asn Tyr
Val Ala Tyr Asn
Val Phe Asn Ser
Val Phe Ser Asn
Val Gly Gln Tyr
Val Gly Tyr Gln
Val His Asn Pro
Val His Pro Asn
Val Asn Ala Tyr
Val Asn Phe Ser
Val Asn His Pro
Val Asn Pro His
Val Asn Ser Phe
Val Asn Tyr Ala
Val Pro His Asn
Val Pro Asn His
Val Gln Gly Tyr
Val Gln Tyr Gly
Val Ser Phe Asn
Val Ser Asn Phe
Val Tyr Ala Asn
Val Tyr Gly Gln
Val Tyr Asn Ala
Val Tyr Gln Gly
Tyr Ala Gly Arg
Tyr Ala Asn Val
Tyr Ala Arg Gly
Tyr Ala Val Asn
Tyr Gly Ala Arg
Tyr Gly Ile Asn
Tyr Gly Leu Asn
Tyr Gly Asn Ile
Tyr Gly Asn Leu
Tyr Gly Gln Val
Tyr Gly Arg Ala
Tyr Gly Val Gln
Tyr Ile Gly Asn
Tyr Ile Asn Gly
Tyr Leu Gly Asn
Tyr Leu Asn Gly
Tyr Asn Ala Val
Tyr Asn Gly Ile
Tyr Asn Gly Leu
Tyr Asn Ile Gly
Tyr Asn Leu Gly
Tyr Asn Val Ala
Tyr Gln Gly Val
Tyr Gln Val Gly
Tyr Arg Ala Gly
Tyr Arg Gly Ala
Tyr Val Ala Asn
Tyr Val Gly Gln
Tyr Val Asn Ala
Tyr Val Gln Gly
AZD8055
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2[1]. AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2[1].
4-METHOXYPHENYL 2-AMINO-3,6-DI-O-BENZYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
tert-Butyl (E)-7-[3-(4-fluorophenyl)-1-methylethyl-indol-2-yl]-3-hydroxy-5-oxo-6-heptenoate
KU-0063794
D004791 - Enzyme Inhibitors KU-0063794 is a potent and specific mTOR inhibitor, inhibiting both the mTORC1 and mTORC2 complexes with IC50s of 10 nM. KU-0063794 is a potent and specific mTOR inhibitor, inhibiting both the mTORC1 and mTORC2 complexes with IC50s of 10 nM.
tert-Butyl (E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoate
Mebeverine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
2-Pyrrolidinone, 1-(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)-4-(2-methylpropyl)-, (4R)-
CID 24906286
Luminespib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
[(3S)-3-acetamido-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-5-oxopentyl]-(diaminomethylidene)-methylazanium
(2R)-2-amino-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylpropanoic acid
N-[2-(tert-butylamino)-2-oxo-1-thiophen-2-ylethyl]-N-(2-oxolanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide
2-[[5-[(2,6-Dimethylphenoxy)methyl]-4-ethyl-1,2,4-triazol-3-yl]thio]-1-(4-phenyl-1-piperazinyl)ethanone
3alpha-hydroxyetiocholan-17-one 3-O-(beta-D-glucuronate)
3-oxo-5alpha-androstan-17beta-yl beta-D-glucopyranosiduronate
[5-[2-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
1-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
1-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
2-methoxy-N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-methoxy-N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-methoxy-N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[(1R)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
5-(4,6-dioxo-3-propan-2-yl-1-cyclohex-2-enylidene)-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide
2-methoxy-N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-methoxy-N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-methoxy-N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-3-(4-fluorophenyl)-1-methylurea
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2,3-dihydro-1H-inden-2-yl)acetamide
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-N-cyclobutyl-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-cyclobutyl-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
4-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(1-oxo-2-phenylethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(1-oxo-2-phenylethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
[(1R)-2-[(4-chlorophenyl)methyl]-1-(cyclopropylmethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
17-oxo-5beta-androstan-3beta-yl beta-D-glucopyranosiduronate
(1E,3E)-5-(3,3-dimethyloxiran-2-yl)-3-methylhexa-1,3-dienyl-quinolinone B
N-(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)-2-[[2-[(2-amino-3-phenylpropanoyl)amino]acetyl]amino]-4-methylpentanamide
(3R,4R)-4,5-dihydroxy-3-methoxy-4-(4-methoxyphenyl)-6-[(E)-2-[(2S,5S)-2-methyl-5-prop-1-en-2-yloxolan-2-yl]ethenyl]-1,3-dihydroquinolin-2-one
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[2-[[(E)-10,16-dichlorohexadec-4-enoyl]-methylamino]-3-methoxypropyl] acetate
(2S)-2-[[[4-[[(2R)-2-amino-3-mercaptopropyl]amino]-2-(1-naphthalenyl)phenyl]-oxomethyl]amino]-4-methylpentanoic acid
5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of 5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
etiocholanolone 3-glucuronide(1-)
A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of etiocholanolone 3-glucuronide.
PE(16:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
YM-58790
YM-58790 is a potent antagonist of mAChR. YM-58790 binds M1, M2, M3 with Ki values of 28 nM, 260 nM, and 15 nM. YM-58790 exhibits potent inhibitory activity on bladder pressuer in reflexly-evoked rhythmic contraction in rats[1].